Search research articles
Contact Us
Filters
Showing results (421-430 of 557) with videos related to
Page
of 56
Sort By:
International Journal of Cancer
|
September 12, 2019
Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals
Simone Leyden, Teodora Kolarova, Catherine Bouvier, et al.
Annals of Surgical Oncology
|
November 6, 2020
The Oncologic Impact of Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma of the Body and the Tail: A Multicenter Retrospective Cohort Analysis
Piera Leon, Fabio Giannone, Giulio Belfiori, et al.
Annals of Surgery
|
May 6, 2024
Reappraising the Role of Intraoperative Neck Margin Revision in Post-Neoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis
Giuseppe Malleo, Gabriella Lionetto, Stefano Crippa, et al.
Oncoimmunology
|
September 14, 2020
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma
Claudia Minici, Elena Rigamonti, Marco Lanzillotta, et al.
Annals of Surgical Oncology
|
December 19, 2019
Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study
Sanne Lof, Maarten Korrel, Jony van Hilst, et al.
Annals of Surgical Oncology
|
November 14, 2019
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Elettra Merola, Anja Rinke, Stefano Partelli, et al.
Endoscopy International Open
|
February 29, 2024
Same-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE)
Giuseppe Vanella, Giuseppe Dell'Anna, Agostino Cosenza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2010
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study
Giuseppe Colucci, Roberto Labianca, Francesco Di Costanzo, et al.
Cell Reports. Medicine
|
February 7, 2024
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer
Veronica Ruta, Chiara Naro, Marco Pieraccioli, et al.
The Journal of Allergy and Clinical Immunology
|
July 19, 2019
B lymphocytes directly contribute to tissue fibrosis in patients with IgG<sub>4</sub>-related disease
Emanuel Della-Torre, Elena Rigamonti, Cory Perugino, et al.
Page
of 56
Search research articles
Search
Showing results (421-430 of 557) with videos related to
Sort By:
Page
of 56
International Journal of Cancer
|
September 12, 2019
Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals
Simone Leyden, Teodora Kolarova, Catherine Bouvier, et al.
Annals of Surgical Oncology
|
November 6, 2020
The Oncologic Impact of Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma of the Body and the Tail: A Multicenter Retrospective Cohort Analysis
Piera Leon, Fabio Giannone, Giulio Belfiori, et al.
Annals of Surgery
|
May 6, 2024
Reappraising the Role of Intraoperative Neck Margin Revision in Post-Neoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis
Giuseppe Malleo, Gabriella Lionetto, Stefano Crippa, et al.
Oncoimmunology
|
September 14, 2020
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma
Claudia Minici, Elena Rigamonti, Marco Lanzillotta, et al.
Annals of Surgical Oncology
|
December 19, 2019
Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study
Sanne Lof, Maarten Korrel, Jony van Hilst, et al.
Annals of Surgical Oncology
|
November 14, 2019
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Elettra Merola, Anja Rinke, Stefano Partelli, et al.
Endoscopy International Open
|
February 29, 2024
Same-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE)
Giuseppe Vanella, Giuseppe Dell'Anna, Agostino Cosenza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2010
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study
Giuseppe Colucci, Roberto Labianca, Francesco Di Costanzo, et al.
Cell Reports. Medicine
|
February 7, 2024
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer
Veronica Ruta, Chiara Naro, Marco Pieraccioli, et al.
The Journal of Allergy and Clinical Immunology
|
July 19, 2019
B lymphocytes directly contribute to tissue fibrosis in patients with IgG<sub>4</sub>-related disease
Emanuel Della-Torre, Elena Rigamonti, Cory Perugino, et al.
Page
of 56